Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding THNR?
Track your performance easily
THNR Price & Analysis
THNR ETF Chart & Stats
Day’s Range― - ―
52-Week Range$22.00 - $28.19
Previous Close$22.63
VolumeN/A
Average Volume (3M)2.33K
AUM4.06M
NAV22.60
Expense Ratio0.59%
Holdings Count30
Beta0.83
Inception DateMay 21, 2024
Last Dividend Ex-Date
Dec 30, 2024Dividend Yield
(0.97%)Shares Outstanding180,000
Standard Deviation0.05
10 Day Avg. Volume34,638
30 Day Avg. Volume2,327
Alpha-0.02
Amplify Weight Loss Drug & Treatment ETF (THNR) Fund Flow Chart
Amplify Weight Loss Drug & Treatment ETF (THNR) 1 year Net Flows: $5M
THNR ETF News
THNR ETF FAQ
What was THNR’s price range in the past 12 months?
THNR lowest ETF price was $22.00 and its highest was $28.19 in the past 12 months.
What is the AUM of THNR?
As of Jan 01, 2025 The AUM of THNR is 4.06M.
Is THNR overvalued?
According to Wall Street analysts THNR’s price is currently Undervalued.
Does THNR pay dividends?
THNR pays a Notavailable dividend of $0.219 which represents an annual dividend yield of 0.97%. See more information on THNR dividends here
How many shares outstanding does THNR have?
THNR has 180,000 shares outstanding.
Which hedge fund is a major shareholder of THNR?
Currently, no hedge funds are holding shares in THNR
THNR ETF Smart Score
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Eli Lilly And Company
15.92%
Novo Nordisk
12.77%
Pfizer Inc
5.62%
Chugai Pharmaceutical Co
5.36%
Thermo Fisher Scientific
5.33%
Roche Holding
4.83%
Teva Pharmaceutical Industries Limited
4.81%
Merck & Company
4.80%
Amgen Inc
4.79%
AstraZeneca
4.76%
Total68.99%
ETF Description
Amplify Weight Loss Drug & Treatment ETF
THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.